<p>. (A) to (C) showed β-AR blockers attenuated cardiac hypertrophy in rats induced by abdominal aortic constriction (AAC). (A) Representative images of hearts. Scale, 5 mm. (B) Ratio of heart weight to body weight. *P<0.05 vs. sham. (C) HE staining of rat hearts and cardiomyocyte cross-sectional diameter (µm). Scale bar, 50 µm. *P<0.05 vs. sham, #P<0.05 vs. AAC. (D) and (E) showed β-AR blocker attenuated Iso-induced cardiac hypertrophy in rats. (D) Ratio of heart weight to body weight. *P<0.05 vs. control. (E) HE staining of rat hearts and cardiomyocyte cross-sectional diameter (µm). Scale bar, 50 µm. Iso, isoproterenol. *P<0.05 vs. control, #P<0.05 vs. Iso.</p
In the present study, we examined whether NF-κB activation is required for cardiac hypertrophy in vi...
<p>(A). Left ventricular posterior wall thickness in end-diastolic (LVPW;d) significantly increased ...
Abstract—Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin I...
<p>(A) and (B) CHOP was increased in AAC rats (4 or 8 weeks after operation), and metoprolol (30 mg/...
<p>(A) ER chaperone GRP78 and spliced XBP-1 were increased in AAC rats (1or 4 or 8 weeks after opera...
<div><p>The change of LVSP (A), +dp/dt<sub>max</sub> (B), LVEDP (C), and -dp/dt<sub>max</sub> (D) in...
It has been shown that converting enzyme inhibitors (CEI) attenuate ventricular dilatation and hyper...
Long-term β-adrenergic receptor (β-AR) blockade reduces mortality in patients with heart failure. Ch...
<p><b>(A).</b> Left Panel: representative example of gross heart morphology. Right Panel: the ratio ...
Background. The degree of cardiac hypertrophy is not only load dependent: Among other factors, the r...
<p><b>A.</b> Representative images. <b>B.</b> Morphometry analyses showing the increase in fiber dia...
Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin II also ex...
<div><p>A. M-mode echocardiography images from Sham-operated (Sham), 8wk post-AAB, and 8wk post-AAB ...
The purpose of this study was to examine the effect of local angiotensin II (ATII) inhibition on amo...
Chronic treatment with β-receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in hear...
In the present study, we examined whether NF-κB activation is required for cardiac hypertrophy in vi...
<p>(A). Left ventricular posterior wall thickness in end-diastolic (LVPW;d) significantly increased ...
Abstract—Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin I...
<p>(A) and (B) CHOP was increased in AAC rats (4 or 8 weeks after operation), and metoprolol (30 mg/...
<p>(A) ER chaperone GRP78 and spliced XBP-1 were increased in AAC rats (1or 4 or 8 weeks after opera...
<div><p>The change of LVSP (A), +dp/dt<sub>max</sub> (B), LVEDP (C), and -dp/dt<sub>max</sub> (D) in...
It has been shown that converting enzyme inhibitors (CEI) attenuate ventricular dilatation and hyper...
Long-term β-adrenergic receptor (β-AR) blockade reduces mortality in patients with heart failure. Ch...
<p><b>(A).</b> Left Panel: representative example of gross heart morphology. Right Panel: the ratio ...
Background. The degree of cardiac hypertrophy is not only load dependent: Among other factors, the r...
<p><b>A.</b> Representative images. <b>B.</b> Morphometry analyses showing the increase in fiber dia...
Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin II also ex...
<div><p>A. M-mode echocardiography images from Sham-operated (Sham), 8wk post-AAB, and 8wk post-AAB ...
The purpose of this study was to examine the effect of local angiotensin II (ATII) inhibition on amo...
Chronic treatment with β-receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in hear...
In the present study, we examined whether NF-κB activation is required for cardiac hypertrophy in vi...
<p>(A). Left ventricular posterior wall thickness in end-diastolic (LVPW;d) significantly increased ...
Abstract—Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin I...